UA66744C2 - 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections - Google Patents

5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections

Info

Publication number
UA66744C2
UA66744C2 UA97010040A UA97010040A UA66744C2 UA 66744 C2 UA66744 C2 UA 66744C2 UA 97010040 A UA97010040 A UA 97010040A UA 97010040 A UA97010040 A UA 97010040A UA 66744 C2 UA66744 C2 UA 66744C2
Authority
UA
Ukraine
Prior art keywords
derivatives
preparation
treatment
dichlorobenzimidazole
methods
Prior art date
Application number
UA97010040A
Other languages
English (en)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of UA66744C2 publication Critical patent/UA66744C2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
UA97010040A 1994-07-07 1995-07-06 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections UA66744C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9413724A GB9413724D0 (en) 1994-07-07 1994-07-07 Therapeutic nucleosides
PCT/GB1995/001597 WO1996001833A1 (en) 1994-07-07 1995-07-06 Therapeutic compounds

Publications (1)

Publication Number Publication Date
UA66744C2 true UA66744C2 (en) 2004-06-15

Family

ID=10757983

Family Applications (1)

Application Number Title Priority Date Filing Date
UA97010040A UA66744C2 (en) 1994-07-07 1995-07-06 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections

Country Status (44)

Country Link
US (4) US6077832A (bg)
EP (1) EP0769017B1 (bg)
JP (1) JP3225045B2 (bg)
KR (1) KR100376075B1 (bg)
CN (2) CN1052010C (bg)
AP (1) AP736A (bg)
AT (1) ATE193298T1 (bg)
AU (1) AU702248B2 (bg)
BG (1) BG63435B1 (bg)
BR (1) BR9508237A (bg)
CY (1) CY2249B1 (bg)
CZ (1) CZ290800B6 (bg)
DE (1) DE69517172T2 (bg)
DK (1) DK0769017T3 (bg)
EE (1) EE03568B1 (bg)
ES (1) ES2147294T3 (bg)
FI (1) FI117629B (bg)
GB (1) GB9413724D0 (bg)
GE (1) GEP20002298B (bg)
GR (1) GR3033744T3 (bg)
HK (1) HK1003711A1 (bg)
HR (1) HRP950382B1 (bg)
HU (1) HU227679B1 (bg)
IL (1) IL114492A (bg)
IS (1) IS1812B (bg)
MD (1) MD1838G2 (bg)
MX (1) MX9606732A (bg)
MY (1) MY117892A (bg)
NO (1) NO308854B1 (bg)
NZ (1) NZ288722A (bg)
OA (1) OA10339A (bg)
PL (1) PL181136B1 (bg)
PT (1) PT769017E (bg)
RO (1) RO117699B1 (bg)
RU (1) RU2145963C1 (bg)
SA (1) SA95160202B1 (bg)
SK (1) SK282046B6 (bg)
TJ (1) TJ270B (bg)
TR (1) TR199500832A2 (bg)
TW (1) TW418196B (bg)
UA (1) UA66744C2 (bg)
WO (1) WO1996001833A1 (bg)
YU (1) YU49443B (bg)
ZA (1) ZA955644B (bg)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9413724D0 (en) * 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides
DE69624827T2 (de) * 1995-08-18 2003-09-04 Univ Michigan Ann Arbor 5'-substitutierte-ribofuranosyl benzimidazolen als antivirale.
GB9518465D0 (en) * 1995-09-09 1995-11-08 Smithkline Beecham Seiyaku Kk Pharmaceuticals
GB9600142D0 (en) * 1996-01-05 1996-03-06 Wellcome Found Chemical compounds
GB9600143D0 (en) * 1996-01-05 1996-03-06 Wellcome Found Therapeutic compounds
WO1997027204A1 (en) * 1996-01-23 1997-07-31 The Regents Of The University Of Michigan Modified benzimidazole nucleosides as antiviral agents
US6576133B2 (en) 1996-11-13 2003-06-10 Transgenomic, Inc Method and system for RNA analysis by matched ion polynucleotide chromatography
US6475388B1 (en) 1996-11-13 2002-11-05 Transgenomic, Inc. Method and system for RNA analysis by matched ion polynucleotide chromatography
GB2319961A (en) * 1996-12-07 1998-06-10 Glaxo Group Ltd Pharmaceutical composition for treatment of restenosis
DE69819695D1 (en) 1997-02-13 2003-12-18 Glaxo Group Ltd Benzimidazolderivate
US6455507B1 (en) * 1997-06-10 2002-09-24 Smithkline Beecham Corporation Benzimidazole derivatives
JP2001512132A (ja) 1997-07-30 2001-08-21 ザ、リージェンツ、オブ、ザ、ユニバーシティ、オブ、ミシガン 抗ウイルス薬としてのリクソフラノシルベンズイミダゾール
US6258264B1 (en) 1998-04-10 2001-07-10 Transgenomic, Inc. Non-polar media for polynucleotide separations
GB9807354D0 (en) 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
GB9807355D0 (en) * 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
US6277830B1 (en) * 1998-10-16 2001-08-21 Schering Corporation 5′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon
US6576265B1 (en) 1999-12-22 2003-06-10 Acell, Inc. Tissue regenerative composition, method of making, and method of use thereof
GB0008939D0 (en) * 2000-04-11 2000-05-31 Glaxo Group Ltd Process for preparing substituted benzimidazole compounds
AU2004253508A1 (en) 2003-06-25 2005-01-13 Acell, Inc. Conditioned matrix compositions for tissue restoration
WO2005063788A1 (ja) * 2003-12-26 2005-07-14 Kissei Pharmaceutical Co., Ltd. ベンズイミダゾール誘導体及びその医薬用途
WO2006115137A1 (ja) * 2005-04-22 2006-11-02 Kissei Pharmaceutical Co., Ltd. ２－アミノベンズイミダゾール誘導体及びその医薬用途
EA008737B1 (ru) * 2005-12-07 2007-08-31 Леонид Андреевич Кожемякин Средство для профилактики и лечения конъюнктивитов и кератитов различной этиологии (варианты), способ его применения
US8940707B2 (en) 2010-10-28 2015-01-27 Viropharma Incorporated Maribavir isomers, compositions, methods of making and methods of using
US8546344B2 (en) 2010-10-28 2013-10-01 Viropharma Incorporated Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole
US8541391B2 (en) 2010-10-28 2013-09-24 Viropharma Incorporated Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazole
WO2012138907A2 (en) * 2011-04-05 2012-10-11 Translational Genomics Research Institute Solid forms of curcumin
EP2867010A1 (en) 2012-06-29 2015-05-06 The Procter & Gamble Company Textured fibrous webs, apparatus and methods for forming textured fibrous webs
ES2885424T3 (es) 2013-03-15 2021-12-13 Knopp Biosciences Llc Imidazo(4,5-B)piridin-2-il amidas como activadores del canal Kv7
US9481653B2 (en) 2014-09-12 2016-11-01 Knopp Biosciences Llc Benzoimidazol-1,2-yl amides as Kv7 channel activators
WO2016086060A1 (en) * 2014-11-26 2016-06-02 The J. David Gladstone Institutes Methods for treating a cytomegalovirus infection
RU2629670C2 (ru) * 2016-08-04 2017-08-31 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) 2-Амино-5,6-дифтор-1-(бета-D-рибофуранозил)-бензимидазол, способ получения и противовирусная активность его в отношении вируса герпеса простого 1-го типа
WO2019183148A1 (en) 2018-03-19 2019-09-26 Knopp Biosciences Llc Kv7 channel activators compositions and methods of use
JP7376108B2 (ja) 2020-06-23 2023-11-08 バイオメトリックス テクノロジーズ インコーポレイテッド 新規なベンズイミダゾール誘導体、その製造方法及びその抗癌剤または抗ウイルス剤としての用途
WO2024081308A1 (en) 2022-10-12 2024-04-18 Takeda Pharmaceutical Company Limited Method of preparing maribavir

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3399987A (en) * 1965-08-02 1968-09-03 United States Borax Chem 2-alkylaminobenzimidazoles as herbicides
CH443777A (de) * 1965-08-06 1968-02-15 Agripat Sa Verfahren zum Schützen textiler Keratinfasern vor Insektenfrass und Mittel zur Durchführung dieses Verfahrens
US3655901A (en) * 1970-07-30 1972-04-11 Merck & Co Inc Method of inhibiting the formation of phenylethanalamine-n-methyl transferase with 2-aminobenzimidazoles
DE2130030A1 (de) * 1971-06-18 1972-12-21 Bayer Ag Fungizide und bakterizide Mittel
US4002623A (en) * 1974-08-07 1977-01-11 Pfizer Inc. Anti-inflammatory 1-[3-(dialkylamino)propyl]-2-acylaminobenzimidazoles and 2-acylamino-3-[3-(dialkylamino)-propyl]imidazo[4,5-b]pyridines
FR2549938B1 (fr) * 1983-07-25 1987-08-07 Fonderie Soc Gen De Bruleur a premelange gazeux et chaudiere equipee d'un tel bruleur
FR2551442B1 (fr) * 1983-09-05 1987-04-30 Centre Nat Rech Scient Nouveaux derives furaniques, leur preparation et leur application
DK405988A (da) * 1987-07-29 1989-01-30 Hoffmann La Roche Benzimidazolderivater
IT1226100B (it) * 1988-07-07 1990-12-10 Dompe Farmaceutici Spa Derivati benzimidazolici farmacologicamente attivi.
SE9003151D0 (sv) * 1990-10-02 1990-10-02 Medivir Ab Nucleoside derivatives
US5248672A (en) * 1990-11-01 1993-09-28 The Regents Of The University Of Michigan Polysubstituted benzimidazole nucleosides as antiviral agents
WO1992018517A1 (en) * 1991-04-17 1992-10-29 Yale University Method of treating or preventing hepatitis b virus
ZA923640B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9205071D0 (en) * 1992-03-09 1992-04-22 Wellcome Found Therapeutic nucleosides
AU5447094A (en) * 1992-10-21 1994-05-09 Regents Of The University Of Michigan, The Polysubstituted benzimidazoles as antiviral agents
US5399580A (en) * 1993-03-08 1995-03-21 Burroughs Wellcome Co. Therapeutic nucleosides-uses
GB9413724D0 (en) * 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides
JP6217655B2 (ja) * 2015-01-15 2017-10-25 トヨタ自動車株式会社 電力変換装置

Also Published As

Publication number Publication date
US6077832A (en) 2000-06-20
OA10339A (en) 1997-10-07
SA95160202B1 (ar) 2005-04-16
NO970040L (no) 1997-01-29
MY117892A (en) 2004-08-30
AU702248B2 (en) 1999-02-18
MD1838G2 (ro) 2002-08-31
FI970032A0 (fi) 1997-01-03
KR100376075B1 (ko) 2004-02-18
YU45095A (sh) 1999-03-04
TJ270B (en) 2000-08-07
DE69517172D1 (de) 2000-06-29
US20010003744A1 (en) 2001-06-14
CZ290800B6 (cs) 2002-10-16
HUT77285A (hu) 1998-03-30
AP9600895A0 (en) 1997-01-31
CN1052010C (zh) 2000-05-03
FI117629B (fi) 2006-12-29
IL114492A (en) 2002-05-23
EE9700013A (et) 1997-06-16
IS4394A (is) 1996-12-09
JP3225045B2 (ja) 2001-11-05
HK1003711A1 (en) 1998-11-06
IL114492A0 (en) 1995-11-27
US5998605A (en) 1999-12-07
GR3033744T3 (en) 2000-10-31
MD1838F2 (en) 2002-01-31
CY2249B1 (en) 2003-07-04
ES2147294T3 (es) 2000-09-01
IS1812B (is) 2002-05-15
PT769017E (pt) 2000-09-29
HU227679B1 (en) 2011-11-28
FI970032A (fi) 1997-01-03
HU9700034D0 (en) 1997-02-28
YU49443B (sh) 2006-03-03
TR199500832A2 (tr) 1996-06-21
MX9606732A (es) 1997-04-30
CN1236616A (zh) 1999-12-01
DK0769017T3 (da) 2000-09-11
BG63435B1 (bg) 2002-01-31
ZA955644B (en) 1997-01-06
RU2145963C1 (ru) 2000-02-27
US6307043B1 (en) 2001-10-23
EP0769017A1 (en) 1997-04-23
HRP950382B1 (en) 2000-12-31
CN1159194A (zh) 1997-09-10
TW418196B (en) 2001-01-11
NZ288722A (en) 1998-07-28
WO1996001833A1 (en) 1996-01-25
ATE193298T1 (de) 2000-06-15
GEP20002298B (en) 2000-11-25
AP736A (en) 1999-03-09
DE69517172T2 (de) 2000-10-19
AU2805195A (en) 1996-02-09
BG101118A (bg) 1998-04-30
SK282046B6 (sk) 2001-10-08
NO970040D0 (no) 1997-01-06
PL318062A1 (en) 1997-05-12
EP0769017B1 (en) 2000-05-24
RO117699B1 (ro) 2002-06-28
NO308854B1 (no) 2000-11-06
CZ4097A3 (en) 1997-08-13
JPH10502356A (ja) 1998-03-03
PL181136B1 (pl) 2001-06-29
HRP950382A2 (en) 1997-08-31
EE03568B1 (et) 2001-12-17
SK168896A3 (en) 1997-09-10
GB9413724D0 (en) 1994-08-24
BR9508237A (pt) 1999-06-01

Similar Documents

Publication Publication Date Title
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
CA2293470A1 (en) Benzimidazole derivatives
UA29429C2 (uk) Фармацевтична композиція для лікування вірусних інфекцій, спосіб отримання композиції, спосіб лікування або профілактики віл-інфекції у людини
MY130035A (en) Antiviral compounds
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
ES8801303A1 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
CA2111580A1 (fr) Composes immunogenes a effet notamment anti-cytokine, procede de preparation, compositions pharmaceutiques et kits les renfermant
ATE175873T1 (de) Weitere indolderivate mit antiviraler wirkung
MX9805441A (es) Compuestos terapeuticos.
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
EP0594795A4 (en) MICHELLAMINES USEFUL AS ANTIVIRAL AGENTS, COMPOSITION AND METHOD OF TREATMENT.
ES2105923A1 (es) Composiciones para el tratamiento de una infeccion y una enfermedad causadas por el virus de la hepatitis b (hbv).
MY111746A (en) Therapeutic nucleosides.
CA2193665A1 (en) Benzimidazole derivatives for the treatment and prophylaxis of virus infections
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
FI943295A (fi) Piliostigma thonningii -uutteet, niiden käyttö ja niitä sisältävät formuloinnit
AU630249B2 (en) Prevention of glycoprotein enveloped virus infectivity by quinolyloxazole-2-ones
HUT73766A (en) Use of 2-methylamino-2-phenyl-cyclohexanone for preparing pharmaceutical compositions against bacterial-, funga, viral or protozoal infections and having immunomodulator effect
TW217986B (en) Compositions for the treatment of infection and disease caused by HBV